Event time: 事件时间:
Published: 文章发布:
Key Results
Actual vs Consensus
EPS: $4.84 vs $4.44 estimate, beat+9.0%.Revenue: $716M vs $714M estimate, in line+0.2%.Profitability and Cash Flow
Period: 2026 Q3 period ended 2026-09-30Revenue: $716M; YoY: +8.5%; QoQ: +1.2%Gross profit: $224M; Gross margin: 31.3%Operating income: $166M; Operating margin: 23.1%; YoY: +16.7%; QoQ: +12.7%Net income: $137M; GAAP diluted EPS: $4.84; YoY: +23.7%; QoQ: +13.3%Operating cash flow: $217M; Capex: $31M; Free cash flow: $186MCash: $705M; Total debt: $146M; Net cash: $559MOfficial release: Medpace Holdings, Inc. Reports Third Quarter 2026 Results
核心结果
实际值与市场预期
EPS:$4.84 vs $4.44 预期,高于预期+9.0%。营收:$716M vs $714M 预期,基本符合预期+0.2%。财务指标
期间:2026 Q3(截至 2026-09-30)营收:$716M;同比:+8.5%;环比:+1.2%毛利润:$224M;毛利率:31.3%经营利润:$166M;经营利润率:23.1%;同比:+16.7%;环比:+12.7%净利润:$137M;GAAP 稀释 EPS:$4.84;同比:+23.7%;环比:+13.3%经营现金流:$217M;资本开支:$31M;自由现金流:$186M现金:$705M;总债务:$146M;净现金:$559M